261 related articles for article (PubMed ID: 18937192)
21. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
Ku GY; Ilson DH
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
[TBL] [Abstract][Full Text] [Related]
22. Preoperative therapy for esophageal cancer.
Ku GY; Ilson DH
Gastroenterol Clin North Am; 2009 Mar; 38(1):135-52, ix. PubMed ID: 19327572
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant therapy for oesophagogastric cancer.
Lordick F; Stein HJ; Peschel C; Siewert JR
Br J Surg; 2004 May; 91(5):540-51. PubMed ID: 15122603
[TBL] [Abstract][Full Text] [Related]
24. [Non-metastasized oesophageal cancer].
Biere SS; van Weyenberg SJ; Verheul HM; Mulder CJ; Cuesta MA; van der Peet DL
Ned Tijdschr Geneeskd; 2010; 154(8):A820. PubMed ID: 21108861
[TBL] [Abstract][Full Text] [Related]
25. Preoperative radiochemotherapy for resectable localised oesophageal cancer: a controversial strategy.
Crehange G; Bonnetain F; Peignaux K; Truc G; Blanchard N; Rat P; Chauffert B; Ghiringhelli F; Maingon P
Crit Rev Oncol Hematol; 2010 Sep; 75(3):235-42. PubMed ID: 20044267
[TBL] [Abstract][Full Text] [Related]
26. [Is there still a role for surgery in esophageal carcinoma in 2007?].
Mariette C; Piessen G; Triboulet JP
Bull Cancer; 2007 Jan; 94(1):63-9. PubMed ID: 17237006
[TBL] [Abstract][Full Text] [Related]
27. [Radiotherapy for locally advanced esophageal cancer].
Fukuhara N; Karasawa K; Kaneyasu Y; Kita-Okawa M; Okawa T
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1841-8. PubMed ID: 9797806
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant treatments for resectable pancreatic cancer.
Ueno H; Kosuge T
J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
[TBL] [Abstract][Full Text] [Related]
29. Multimodality therapy for cancers of the esophagus and gastric cardia.
Naughton P; Walsh TN
Expert Rev Anticancer Ther; 2004 Feb; 4(1):141-50. PubMed ID: 14748664
[TBL] [Abstract][Full Text] [Related]
30. Surgical treatment for esophageal cancer. Current issues.
Kato H; Fukuchi M; Miyazaki T; Nakajima M; Tanaka N; Inose T; Kimura H; Faried A; Saito K; Sohda M; Fukai Y; Masuda N; Manda R; Ojima H; Tsukada K; Kuwano H
Dig Surg; 2007; 24(2):88-95. PubMed ID: 17446703
[TBL] [Abstract][Full Text] [Related]
31. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma (Br J Surg 2009; 96: 1300-1307).
Clark E; Krishnan A; Dunn LJ; Robertson AG; Griffin SM
Br J Surg; 2010 May; 97(5):792-3; author reply 793. PubMed ID: 20393986
[No Abstract] [Full Text] [Related]
32. Role of neoadjuvant therapy for esophageal adenocarcinoma.
Ku GY; Ilson DH
Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
[TBL] [Abstract][Full Text] [Related]
33. Overall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experience.
Idelevich E; Buyevich V; Machlenkin S; Ziv-Sokolovsky N; Dinerman M; Brenner B; Kashtan H
Onkologie; 2008 Dec; 31(12):673-7. PubMed ID: 19060505
[TBL] [Abstract][Full Text] [Related]
34. [Radiotherapy and chemotherapy in the treatment of oesophageal carcinoma].
Mariette C; Triboulet JP
Ann Chir; 2004 Nov; 129(9):489-96. PubMed ID: 15556577
[TBL] [Abstract][Full Text] [Related]
35. Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer.
Bystricky B; Okines AF; Cunningham D
Drugs; 2011 Mar; 71(5):541-55. PubMed ID: 21443280
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer.
Kranzfelder M; Schuster T; Geinitz H; Friess H; Büchler P
Br J Surg; 2011 Jun; 98(6):768-83. PubMed ID: 21462364
[TBL] [Abstract][Full Text] [Related]
37. [Future perspectives on the standardization of surgical treatment for esophageal cancer].
Ando N
Nihon Geka Gakkai Zasshi; 2003 May; 104(5):390-4. PubMed ID: 12774522
[TBL] [Abstract][Full Text] [Related]
38. Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues.
Chang F; Deere H; Mahadeva U; George S
Am J Clin Pathol; 2008 Feb; 129(2):252-62. PubMed ID: 18208806
[TBL] [Abstract][Full Text] [Related]
39. [Esophageal carcinoma: downstaging or stent?].
Grund KE; Noetzel J; Zindel C
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():755-8. PubMed ID: 9101982
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy for pancreas cancer: advances and controversies.
Mulcahy MF
Semin Oncol; 2007 Aug; 34(4):321-6. PubMed ID: 17674960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
